| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4410553fa514ec20fab08e96db05580 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-186 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25ba3ff8ba21c200ef6cbbf65748b12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1843031837602c7ecc70e8f599678111 |
| publicationDate |
2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2744864-T3 |
| titleOfInvention |
Enhancing agents for transdermal and transmucosal drug delivery |
| abstract |
Composition comprising: (a) 3- (4-propylheptyl) -4-morpholine-ethanol or a pharmaceutically acceptable salt thereof, 4- (2-propylpentyl) -1-piperidine-ethanol or a pharmaceutically acceptable salt thereof, or 4- (2-hydroxyethyl) -4-methyl-3- (4- propylheptyl) morpholinium chloride; and (b) a pharmacologically active agent selected from the group consisting of an analgesic, nicotinic acid, and a peptide. |
| priorityDate |
2007-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |